|
Anapafseos 5 Agios Nikolaos 72100,Crete,Greece,00302841026182,00306932607174,alsfakia@gmail.com
Blog Archive
- ► 2022 (3010)
-
▼
2021
(9899)
-
▼
November
(684)
-
▼
Nov 15
(25)
- Facile synthesis of novel Bi(0)-SBA-15 adsorbents ...
- Reconstruction of fingertip defects with the anter...
- A reverse form of Linburg-Comstock variation with ...
- Localization of the neuropeptide manserin in rat d...
- Salivary HPV Persistence Following Treatment of Or...
- Chronic Rhinosinusitis Outcomes of Patients With A...
- Evaluation of tumor response three months after co...
- Ramadan fasting during treatment with external bea...
- Moxetumomab pasudotox-Third line in Hairy cell leu...
- Medicinal plants used by patients to fight cancer
- Differences between radioactive iodine-induced sia...
- Summary document on safety and recommendations for...
- Translating Access to Outcomes: The Impact of Soci...
- A supportive donor nerve for long-term facial para...
- Head and neck research in plastic surgery-Ahead of...
- A single-center experience with head-to-toe micros...
- Electrode array design determines scalar position,...
- Orbito-Cranial Gunshot Injuries with Retained Sino...
- Ewing Sarcoma of the Ethmoid Sinus in an Adult
- Increased Risk of Postpartum Depression in Women W...
- Time management in operating rooms-a cross-section...
- Radiation‐Associated Sarcoma of the Head and Neck:...
- Granulomatose mit Polyangiitis – Manifestationen i...
- Phoniatricians and otorhinolaryngologists approach...
- SUVmax for predicting regional control in orophary...
-
▼
Nov 15
(25)
-
▼
November
(684)
- ► 2020 (4138)
- ► 2019 (2429)
Αλέξανδρος Γ. Σφακιανάκης
Monday, November 15, 2021
Moxetumomab pasudotox-Third line in Hairy cell leukemia
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment